Brain injury following cardiac arrest: Pathophysiology for neurocritical care

Journal of Intensive Care

Volumn 4, Issue 1, 2016, Pages

  Uchino, Hiroyuki ^a   Ogihara, Yukihiko ^a   Fukui, Hidekimi ^a   Chijiiwa, Miyuki ^a   Sekine, Shusuke ^a   Hara, Naomi ^a   Elmér, Eskil ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Calcineurin immunophilin; Cardiac arrest; Excitotoxicity; Mitochondrial dysfunction; Mitochondrial permeability transition (MPT); Pathophysiology of ischemic brain damage; Post cardiac arrest syndrome (PCAS); Reperfusion injury

Indexed keywords

CALCINEURIN; GLUTAMIC ACID; IMMUNOPHILIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BRAIN BLOOD FLOW; BRAIN INJURY; CALCIUM HOMEOSTASIS; CELL DEATH; CELL FUNCTION; DEPOLARIZATION; DISORDERS OF HIGHER CEREBRAL FUNCTION; EXCITOTOXICITY; HEART ARREST; INFLAMMATION; INTENSIVE CARE; MITOCHONDRIAL PERMEABILITY; NERVE DEGENERATION; NITRATIVE STRESS; OXIDATIVE STRESS; OXYGEN SATURATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84991031154     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-016-0140-9     Document Type: Review

References (78)

1. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al. Part 9: post-cardiac arrest care: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S768-86.
2. Uchino H, Elmér E, Uchino K, Lindvall O, Siesjö BK. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand. 1995;155(4):469-71.
3. Uchino H, Kuroda Y, Morota S, Hirabayashi G, Ishii N, Shibasaki F, Ikeda Y, Hansson MJ, Elmér E.Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction andcalcineurin activation. J Anesth. 2008;22(3):253-62.
4. Cho TH, Aguettaz P, Campuzano O, Charriaut-Marlangue C, Riou A, Berthezène Y, et al. Pre-and post-treatment with cyclosporine A in a rat model of transient focal cerebral ischaemia with multimodal MRI screening. Int J Stroke. 2013;8(8):669-74. doi:10.1111/j.1747-4949.2012.00849.x. Epub 2012 Aug 7.
5. Mbye LH, Singh IN, Carrico KM, Saatman KE, Hall ED. Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J Cereb Blood Flow Metab. 2009;29(1):87-97. doi:10.1038/jcbfm.2008.93. Epub 2008 Aug 20.
6. Sullivan PG, Sebastian AH, Hall ED. Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury. J Neurotrauma. 2011;28(2):311-8. doi:10.1089/neu.2010.1646. Epub 2011 Feb 2.
7. Popp E, Bottiger BW. Cerebral resuscitation: state of the art, experimental approaches and clinical perspectives. Neurol Clin. 2006;24(1):73-87. doi:10.1016/j.ncl.2005.10.008. vi.
8. Siesjo BK, Siesjo P. Mechanisms of secondary brain injury. Eur J Anaesthesiol. 1996;13(3):247-68.
9. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341(Pt 2):233-49.
10. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie. 2002;84(2-3):241-50.
11. Kroemer G. The mitochondrial permeability transition pore complex as a pharmacological target. An introduction. Curr Med Chem. 2003;10(16):1469-72.
12. Wieloch T, Mattiasson G, Hansson MJ, Elmér E. Mitochondrial permeability transition in the CNS-composition, regulation, and pathophysiological relevance. Handbook of Neurochemistry and Molecular Neurobiology-Brain Energetics. Integration of Molecular and Cellular Processes. 3 ed. Berlin: Springer. 2007. p. 667-702.
13. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol. 2002;40(12):2110-6.
14. Gazmuri RJ, Becker J. Cardiac resuscitation. The search for hemodynamically more effective methods. Chest. 1997;111(3):712-23.
15. Ristagno G, Tang W, Huang L, Fymat A, Chang YT, Sun S, et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med. 2009;37(4):1408-15. doi:10.1097/CCM.0b013e31819cedc9.
16. Chalkias A, Xanthos T. Pathophysiology and pathogenesis of postresuscitation myocardial stunning. Heart Fail Rev. 2012;17(1):117-28. doi:10.1007/s10741-011-9255-1.
17. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitation-contraction coupling. Antioxid Redox Signal. 2000;2(1):55-64.
18. Huet O, Dupic L, Batteux F, Matar C, Conti M, Chereau C, et al. Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med. 2011;39(7):1712-20. doi:10.1097/ CCM.0b013e3182186d42.
19. Xu K, Puchowicz MA, Sun X, LaManna JC. Decreased brainstem function following cardiac arrest and resuscitation in aged rat. Brain Res. 2010;1328:181-9. doi:10.1016/j.brainres.2010.02.080.
20. Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130(4S Suppl):1007S-15S.
21. Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, Wieloch T, et al. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res. 2003;960(1-2):99-111.
22. Rivers EP, Martin GB, Smithline H, Rady MY, Schultz CH, Goetting MG, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med. 1992;21(9):1094-101.
23. Cerchiari EL, Safar P, Klein E, Diven W. Visceral, hematologic and bacteriologic changes and neurologic outcome after cardiac arrest in dogs. The visceral post-resuscitation syndrome. Resuscitation. 1993;25(2):119-36.
24. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23(9):1261-76. doi:10.1002/neu.480230915.
25. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391-7.
26. Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 2003;3(2):65-94. doi:10.1385/NMM:3:2:65.
27. Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp. 1999;66:181-203.
28. Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci. 2005;1047:248-58. doi:10.1196/annals.1341.022.
29. Terasaki Y, Liu Y, Hayakawa K, Pham LD, Lo EH, Ji X, et al. Mechanisms of neurovascular dysfunction in acute ischemic brain. Curr Med Chem. 2014;21(18):2035-42.
30. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 2003;304(3):463-70.
31. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004;61(3):372-85. doi:10.1016/S0008-6363(03)00533-9.
32. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res. 2005;79(1-2):231-9. doi:10.1002/jnr.20292.
33. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A. 2005;102(34):12005-10. doi:10.1073/pnas.0505294102.
34. Schneider MD. Cyclophilin D: knocking on death's door. Sci STKE. 2005; 2005(287):e26. doi:10.1126/stke.2872005pe26.
35. Hansson MJ, Mansson R, Mattiasson G, Ohlsson J, Karlsson J, Keep MF, et al. Brain-derived respiring mitochondria exhibit homogeneous, complete and cyclosporin-sensitive permeability transition. J Neurochem. 2004;89(3):715-29. doi:10.1111/j.1471-4159.2004.02400.x.JNC2400.
36. Hansson MJ, Mattiasson G, Mansson R, Karlsson J, Keep MF, Waldmeier P, et al. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J Bioenerg Biomembr. 2004;36(4):407-13. doi:10.1023/B:JOBB.0000041776.31885.45. 490863.
37. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30(11):2126-8. doi:10.1007/s00134-004-2425-z.
38. Huang L, Weil MH, Tang W, Sun S, Wang J. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med. 2005;33(3):487-91.
39. Rivers EP, Wortsman J, Rady MY, Blake HC, McGeorge FT, Buderer NM. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest. 1994;106(5):1499-507.
40. Ruiz-Bailen M, de Hoyos Aguayo E, Ruiz-Navarro S, Diaz-Castellanos MA, Rucabado-Aguilar L, Gomez-Jimenez FJ, et al. Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation. 2005;66(2):175-81. doi:10.1016/j.resuscitation.2005.01.012.
41. Adams JA. Endothelium and cardiopulmonary resuscitation. Crit Care Med. 2006;34(12 Suppl):S458-65. doi:10.1097/01.CCM.0000246012.68479.49.
42. Esmon CT. Coagulation and inflammation. J Endotoxin Res. 2003;9(3):192-8. doi:10.1179/096805103125001603.
43. Bottiger BW, Motsch J, Bohrer H, Boker T, Aulmann M, Nawroth PP, et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation. 1995;92(9):2572-8.
44. Adrie C, Monchi M, Laurent I, Um S, Yan SB, Thuong M, et al. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway. J Am Coll Cardiol. 2005;46(1):21-8. doi:10.1016/j.jacc.2005.03.046.
45. Hekimian G, Baugnon T, Thuong M, Monchi M, Dabbane H, Jaby D, et al. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock. 2004;22(2):116-9.
46. Schultz CH, Rivers EP, Feldkamp CS, Goad EG, Smithline HA, Martin GB, et al. A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med. 1993;21(9):1339-47.
47. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215. doi:10.1161/CIRCULATIONAHA.109.192667.
48. Krause GS, Kumar K, White BC, Aust SD, Wiegenstein JG. Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects for protection. Am Heart J. 1986;111(4):768-80.
49. Vannucci RC. Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000;17(3):113-20. doi:10.1055/s-2000-9293.
50. Fraser PA. The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med. 2011;51(5):967-77. doi:10.1016/j.freeradbiomed.2011.06.003.
51. Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans. 2006;34(Pt 2):232-7. doi:10.1042/BST20060232.
52. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40(5):e331-9. doi:10.1161/STROKEAHA.108.531632.
53. Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Huttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol. 2013;47(1):9-23. doi:10.1007/s12035-012-8344-z.
54. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem. 2003;278(38):36027-31. doi:10.1074/jbc.M304854200.
55. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336(23):1629-33. doi:10.1056/ NEJM199706053362302.
56. Lai CS, Hostler D, D'Cruz BJ, Callaway CW. Prevalence of troponin-T elevation during out-of-hospital cardiac arrest. Am J Cardiol. 2004;93(6):754-6. oi:10.1016/j.amjcard.2003.11.068.
57. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82(4):203-5.
58. Courtney DM, Kline JA. Prospective use of a clinical decision rule to identify pulmonary embolism as likely cause of outpatient cardiac arrest. Resuscitation. 2005;65(1):57-64. doi:10.1016/j.resuscitation.2004.07.018.
59. Ornato JP, Ryschon TW, Gonzalez ER, Bredthauer JL. Rapid change in pulmonary vascular hemodynamics with pulmonary edema during cardiopulmonary resuscitation. Am J Emerg Med. 1985;3(2):137-42.
60. Morimoto Y, Kemmotsu O, Kitami K, Matsubara I, Tedo I. Acute brain swelling after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med. 1993;21(1):104-10.
61. Cali T, Ottolini D, Brini M. Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium. 2012;52(1):73-85. doi:10.1016/j.ceca.2012.04.015.
62. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem. 1997;272(6):3346-54.
63. Ahmad M, Dar NJ, Bhat ZS, Hussain A, Shah A, Liu H, et al. Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets. CNS Neurol Disord Drug Targets. 2014;13(8):1378-96.
64. Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis. 2010;20 Suppl 2:S369-79. doi:10.3233/JAD-2010-100543.
65. Knoll G, Brdiczka D. Changes in freeze-fractured mitochondrial membranes correlated to their energetic state. Dynamic interactions of the boundary membranes. Biochim Biophys Acta. 1983;733(1):102-10.
66. Crompton M, Barksby E, Johnson N, Capano M. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie. 2002;84(2-3):143-52.
67. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434(7033):658-62. doi:10.1038/nature03434.
68. Gajavelli S, Sinha VK, Mazzeo AT, Spurlock MS, Lee SW, Ahmed AI, et al. Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury. J Bioenerg Biomembr. 2015;47(1-2):133-48. doi:10.1007/ s10863-014-9589-1.
69. Hansson MJ, Morota S, Chen L, Matsuyama N, Suzuki Y, Nakajima S, et al. Cyclophilin D-sensitive mitochondrial permeability transition in adult human brain and liver mitochondria. J Neurotrauma. 2011;28(1):143-53. doi:10.1089/neu.2010.1613.
70. Uchino H, Hatakeyama K, Morota S, Tanoue T, Nishiyama T, Usui D, et al. Cyclophilin-D inhibition in neuroprotection: dawn of a new era of mitochondrial medicine. Acta Neurochir Suppl. 2013;118:311-5. doi:10.1007/978-3-7091-1434-6_61.
71. Vinogradov A, Scarpa A, Chance B. Calcium and pyridine nucleotide interaction in mitochondrial membranes. Arch Biochem Biophys. 1972;152(2):646-54.
72. Hunter DR, Haworth RA, Southard JH. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem. 1976;251(16):5069-77.
73. Hirakawa A, Takeyama N, Nakatani T, Tanaka T. Mitochondrial permeability transition and cytochrome c release in ischemia-reperfusion injury of the rat liver. J Surg Res. 2003;111(2):240-7.
74. Takeyama N, Miki S, Hirakawa A, Tanaka T. Role of the mitochondrial permeability transition and cytochrome C release in hydrogen peroxideinduced apoptosis. Exp Cell Res. 2002;274(1):16-24.
75. Wang JH, Desai R. A brain protein and its effect on the Ca2 + -and protein modulator-activated cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun. 1976;72(3):926-32.
76. Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66(4):807-15.
77. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 1997;386(6626):728-31. doi:10.1038/386728a0.
78. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 1999;284(5412):339-43.